Burkitt's lymphoma is characterised by a typical cytogenetic abnormality-the translocation of an oncogene (c-myc) containing fragments of chromosome 8 to the sites of immunoglobulin heavy or light chain genes in chromosomes 14, 2, or 22.1 Besides the specific chromosomal translocations a proportion of Burkitt type tumours contain secondary chromosomal abnormalities2-5 that are also detectable by flow cytometric DNA analysis.6 In chronic lymphocytic leukaemia (CLL) and immunocytoma comparable chromosomal changes indicate a poor prognosis.
The recently described analysis of nuclear DNA content of formalin fixed, paraffin embedded material8 has also been successfully used on nonHodgkin lymphomas (NHL). 9 We report the analysis by flow cytometry of 26 archival, non-endemic, Burkitt type tumours. The nuclear DNA content and proliferative activity of the tumours were correlated with histological and clinical follow up data.
Material and methods
Twenty six newly diagnosed cases of NHL classified as small non-cleaved Burkitt type lymphomas were studied. 10 The biopsy material was collected during 1965-85 from the catchment area of Tampere University Central Hospital which had about 410 000 inhabitants before 1980, with an incidence of 15 NHL.II After boundary reorganisation the region expanded to about 1 000 000 people and an additional 11 cases were found during 1981-85. The mean age of the patients was 36 (range four to 69 years); nine patients were younger than 15 years; 13 were between 16 and 60 years; and four were over 61 years of age. None of the patients had previously been treated for malignant disease or had received immunosuppressive drugs. Because of the retrospective nature of the study, patients' treatment varied considerably from no treatment to radiotherapy alone, or chemotherapy and radiotherapy with various combinations.
Diagnostic, formalin fixed tumour biopsy specimens were available from 25 patients. Fresh frozen tumour biopsy specimens were available from four patients.
Clinical staging was done according to the Ann Arbor system.'2 Eleven patients were classified as having disease of stages I-II and 10, stages III-IV. Two patients (aged 8 and 19 years) had acute lymphoblastic leukaemia, which was shown by a bone marrow aspirate to have Burkitt type cell infiltration. Three patients had no staging reported in their medical records.
The histopathological analysis of the lymphoma biopsy specimens has already been described thoroughly.' The tumours were classified according to their growth patterns into follicular, follicular and diffuse, and diffuse.'3 A mitotic ratio of the tumours was determined by calculating the lymphoid cells and mitotic activity by using an ocular square and lens 1201 Lehtinen, Lehtinen, Aine 20 Fisher's exact test was also used. Only patients followed up for three years or longer were included in the analyses.
Results

ANALYSIS OF THE NUCLEAR DNA CONTENT OF THE TUMOURS
No major differences between the quality of the DNA histograms obtained from the fresh-frozen biopsy specimens and the paraffin embedded material were noticed ( fig 1) . The nuclear DNA content of the Burkitt type tumours was analysed from the formalin fixed, paraffin embedded material, available from all patients (except for one case of Burkitt type leukaemia, from which only fresh-frozen biopsy specimen was analysed). The coefficient of variation of all the 25 paraffin embedded samples varied between 3-1 and 89% (mean 57).
We found eight (31%) aneuploid tumours. The mean DNA index was 1 14 (range 1 08-1 24) for the six aneuploid tumours, which were almost diploid (fig 2) . The two aneuploid tumours in the tetraploid region had DNA indices of 1 88 and 1 98. Generally, the aneuploid peaks were about as prominent as the diploid peaks (table 1). The S-phase fraction could reliably be calculated from 24 tumours. The mean S-phase fraction of these 24 tumours was 15 5. Only two tumours, one aneuploid and one diploid, showed low S-phase fraction of 3-4 and 4-6, respectively. For the aneuploid tumours, the mean S-phase fraction was 14 1 (range 34-277) and for the diploid tumours it was 159 (range 4 6-26-3). The aneuploid tumours did not show enhanced proliferative or mitotic activity, the common characteristics of tumours, including NHL, indicating poor prognosis. 4 17 24 Abnormal mitotic activity has been suggested to be one of the possible mechanisms through which aneuploidy evolves.25 26 In our material it was the diploid tumours that showed aberrant mitoses, whereas only one such case was found in the group with aneuploid tumours. Our 
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